Xinmailong Injection Attenuates Doxorubicin-Induced Chronic Heart Failure by Regulating the SIRT1/Caspase-3 Axis and Metabolic Reprogramming: An Integrative Network Pharmacology and Metabolomics Study
- DOI
- 10.1007/s11596-026-00238-0
- Published
- 2026-09-18
- Container
- Current Medical Science
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s11596-026-00238-0,
title = {Xinmailong Injection Attenuates Doxorubicin-Induced Chronic Heart Failure by Regulating the SIRT1/Caspase-3 Axis and Metabolic Reprogramming: An Integrative Network Pharmacology and Metabolomics Study},
author = {Chang-ling Lv and Yan-Ni Xue and De-xiao Wang and Lu Jin and Di Tan and Ding-yu Wu and Fang Peng},
year = {2026},
journal = {Current Medical Science},
doi = {10.1007/s11596-026-00238-0},
url = {https://doi.org/10.1007/s11596-026-00238-0}
}RIS
TY - JOUR TI - Xinmailong Injection Attenuates Doxorubicin-Induced Chronic Heart Failure by Regulating the SIRT1/Caspase-3 Axis and Metabolic Reprogramming: An Integrative Network Pharmacology and Metabolomics Study AU - Chang-ling Lv AU - Yan-Ni Xue AU - De-xiao Wang AU - Lu Jin AU - Di Tan AU - Ding-yu Wu AU - Fang Peng PY - 2026 JO - Current Medical Science DO - 10.1007/s11596-026-00238-0 UR - https://doi.org/10.1007/s11596-026-00238-0 ER -
APA
Lv, C., Xue, Y., Wang, D., Jin, L., Tan, D., Wu, D., & Peng, F. (2026). Xinmailong Injection Attenuates Doxorubicin-Induced Chronic Heart Failure by Regulating the SIRT1/Caspase-3 Axis and Metabolic Reprogramming: An Integrative Network Pharmacology and Metabolomics Study. Current Medical Science. https://doi.org/10.1007/s11596-026-00238-0
Source records
- crossref · retrieved 2026-09-25T04:16:51.948Z